Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis - Test2 - elhamkhani - TriplyDB

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

http://www.wikidata.org/entity/Q35073965

about

Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners HIV, sexual violence and special populations: adolescence and pregnancy Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli.Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators Human cathelicidin production by the cervix NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW Bacterial vaginosis and the cervicovaginal immune response.Polymicrobial challenges to Koch's postulates: ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes.Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually active female adolescents.Development of an in vitro alternative assay method for vaginal irritation.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay.Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.Retrocyclins and their activity against HIV-1.The Human Microbiome during Bacterial Vaginosis.Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal Fluid Association of bactericidal activity of genital tract secretions with Escherichia coli colonization in pregnancy Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition.Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner Associations between vaginal bacteria and levels of vaginal defensins in pregnant women.Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.Changes in the soluble mucosal immune environment during genital herpes outbreaks.Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.On the physiology and pathophysiology of antimicrobial peptides.Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.Engineering tissue alternatives to animals: applying tissue engineering to basic research and safety testing.Defensins in viral infections.

P2860

Q24629785-D0581A8C-7F6D-4DFF-BF7B-41A1460B4B0E Q26825943-595EC144-E215-4433-BA35-1EB80C7A9E73 Q28081831-AB28D20F-D08C-48C4-AACC-C9CEDA17ED1E Q28087327-EF6C64AA-950C-4D17-BCED-69A54D01A641 Q28731648-E4A9484F-41F7-4AE4-99F1-94D7C7C91310 Q30447923-4DE3555A-E810-4EC8-8773-7F3E701D100B Q33578080-F072A2F8-5093-42B0-8513-1B33AA73C9EA Q33999185-373529BA-10F1-44DD-B697-1186491FC4BA Q33999248-6665359F-122E-40B9-A170-3004BEAE3F6F Q34013627-B6BB7184-87CF-4230-A5B3-5C5107D395D4 Q34027489-84C311E5-B6E7-47A0-83C0-94B63D5FCFE0 Q34179233-9887569A-06D3-4538-998E-685149F80994 Q34193360-7047D7B6-4EE1-4B54-B8E6-C53178589C38 Q34342009-3DDB7E27-55C0-482F-81B6-05B128AC5686 Q34414296-AD7AEE99-B996-4A26-AE33-5744CECE2EC2 Q34467932-515B8D08-9E8B-4AB5-A777-B645DBAFC634 Q34483035-C37846C7-FBF6-419B-92E4-4082E6BFC6AE Q34490101-E27845EA-2BE0-415B-AD11-452770ABA1EB Q34589778-24B4903E-7873-439B-809E-E71F9724BBAD Q35136126-69B91F01-DBE3-4112-9441-D1582B303885 Q35879590-0CBA6AFF-6E72-4418-B4CF-109E24A53F31 Q35920191-575202EF-F0C9-49A9-903A-405671AC8F8C Q36068677-6D4FD2BF-5B83-4F67-9E97-2F4BAA2D5B68 Q36082673-B6447694-5FA7-4A36-9DE7-A8361E9C431D Q36291485-F848ECDC-31CC-4E68-8AFD-8134358FF8F5 Q36294689-03B2A057-F17B-4A08-95BD-C72A290F533C Q36294698-2C3CC827-41C7-443F-95D3-2CBFE7DF4924 Q36409878-48CD6023-7A24-4128-A074-E012A25382CB Q36412234-045DC632-DCBF-4D46-83F4-4F930A57A453 Q36471518-715CA3E8-56A5-4E07-8CFB-0C64A1B41129 Q36661434-CB032E03-B821-432D-B238-4308FB2C0FA9 Q36758214-4AF5505B-B0CD-427D-9F29-ED3F7D58667F Q36927695-C2F1DC47-C6AE-4738-BCF4-084892083859 Q36937188-F28F0A11-C930-4C9D-A645-F4A1A6FCBFAB Q36966645-666BD7E8-B3A3-4645-82F8-8C0ECD8E415C Q36996000-7171F148-1CDE-446A-BE26-E8D3884DEB40 Q37327972-B5D3AC7D-9718-4530-A1E3-614143A1E735 Q37346674-C4B66B0A-BB8E-4956-AC2D-0A9D6F03674E Q37542225-970921A9-CF4B-4698-8E65-1A5576620E6B Q37726739-74E19AAC-984E-4555-8FEC-D69984786F77

P2860

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

http://www.wikidata.org/entity/Q35073965

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

@ast

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

@en

type

label

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

@ast

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

@en

prefLabel

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

@ast

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

@en

P1433

Q35073965-A0077C14-5E6A-455C-9260-F58764309813

P1476

Q35073965-F67105B3-0EFE-480D-9FEC-0DC58E01627E

P2093

Q35073965-A9C21080-FA17-4498-95F0-9917A1FB604D

Q35073965-D6228CCE-155D-4195-8B63-FDE38B136023

P2860

Q35073965-0CD48161-5160-4276-AB93-C7BA7FFB99EE

Q35073965-1431F335-2B59-41EB-BBE5-D4CCA2ECFAE5

Q35073965-1FA987EF-9B2E-4153-B89C-761A6C3BA3E8

Q35073965-21A169BF-D30A-4007-81FA-893E8A8D2E2F

Q35073965-21B0C562-2D4F-43DA-85BC-AE25A6D76761

Q35073965-26461FFB-6B70-44F3-B476-17937F148399

Q35073965-2AF36E0F-4729-41FA-8792-1620A383F6C7

Q35073965-3DA495FA-9692-4B60-9D9E-31EEE7FFD555

Q35073965-42D5B004-ED1C-4A0F-9A83-87A1E3DE3F70

Q35073965-464EB566-CD27-4314-9C5E-3E259231533E

P304

Q35073965-37E04541-86BF-46A3-A034-4305ECB1366C

P31

Q35073965-02D953D0-6047-4E0B-9E2C-1D9C2C4DA6D4

P356

Q35073965-1715C2E5-F502-4C1E-94F6-CE48109F441B

P407

Q35073965-A296FA1F-B266-4935-9CF8-DDC632DBAFD5

P433

Q35073965-43CDF025-AFC2-4080-B37B-8AC3D0CEEF16

P478

Q35073965-860AF217-6F3B-4F0B-BACE-267DF54551F6

P50

Q35073965-70053883-977B-4E58-B485-BE25B4EC15A4

P577

Q35073965-F90AAC69-4ACA-43EC-AA91-966B0FA9DE6C

P698

Q35073965-9AE22C0C-B873-4B07-B6E8-7B72D0743CD4

P932

Q35073965-9640BC12-7760-4683-B306-B1E4A8E3F705

P356

P1433

Infection and Immunity

P1476

Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis

@en

P2093

Dorothy J Wiley

http://www.w3.org/2001/XMLSchema#string

Erika V Valore

http://www.w3.org/2001/XMLSchema#string

P2860

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

Localization of human intestinal defensin 5 in Paneth cell granules

Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

Toll-like receptors

Factors Associated with Acquisition of, or Persistent Colonization by, Vaginal Lactobacilli: Role of Hydrogen Peroxide Production

Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.

Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.

Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.

P304

5693-5702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00524-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16988245

http://www.w3.org/2001/XMLSchema#string

P932

1594936

http://www.w3.org/2001/XMLSchema#string